SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

Renewed tariff threats against European allies, stemming from the Greenland situation, are currently dominating market discourse for SPY and impacting futures. While some investors anticipate a significant market pullback, many view any dip as a familiar "buy the dip" opportunity, expecting a rapid recovery as markets have previously navigated similar geopolitical "drama". The community is actively debating the potential for broader trade implications and forthcoming economic and political developments to shape near-term direction.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is drawing considerable attention following its recent acquisition of VLX-1005, expanding its pipeline beyond a single asset, alongside ongoing progress for its flagship tecarfarin toward Phase 3 trials and manufacturing readiness. The community is actively debating its ultra-low float and the potential for tecarfarin to revolutionize anticoagulation therapy, with some analysts issuing high price targets. This discussion is set against concerns over past offerings and potential dilution, highlighting a polarized but active market interest in the microcap biotech.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing a surge in attention following significant global approvals for its Anktiva cancer therapy, notably for lung and bladder cancer, challenging established treatment paradigms. This development, combined with high short interest and the company's leadership actively promoting the science, has fueled community discussions around a potential short squeeze and a transformative shift in the biotech sector. Investors are keenly focused on the accelerated revenue prospects and broader market adoption of these innovative treatments.

KiboShib (KIBSHI) is the first AI-generated meme coin. On December 8th 2022, AI was tasked with creating a meme coin. It all started as a joke, but the idea which was proposed by the AI is so powerful that nobody could resist! The AI even suggested a logo design which later has been fed to the AI image generator. The age of AI is upon us, and KiboShib stands for exploring the capabilities of AI with a hopeful outlook.

KiboShib

KIBSHI CRYPTO is trending as the community rallies around its unique narrative as the first AI-generated meme coin, created by ChatGPT in 2022. This narrative, combined with growing AI hype, fuels discussions about its potential for substantial gains, with many comparing it to the early explosive runs of $DOGE and $SHIB. Investors are actively discussing its low market capitalization and positioning for what they anticipate could be a significant opportunity in the upcoming altcoin cycle.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network (ROSE) is trending amidst a strong pivot towards AI and privacy, highlighted by a recent rebrand and ongoing developments leveraging Trusted Execution Environments for secure data. The community is actively discussing its potential as an undervalued asset, anticipating significant growth within the booming privacy and AI crypto sectors. This positions ROSE as a key contender addressing critical demands for data security in Web3.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is experiencing significant recent volatility and a notable pullback, sparking intense community debate. While bulls highlight strong fundamental growth from its AI-powered AXON platform and recent analyst upgrades as a "buy the dip" opportunity, bears point to circulating short report rumors and broader ad-tech sector weakness, alongside discussions of options market dynamics, as reasons for the sharp decline. This creates a highly active discussion about the stock's near-term direction ahead of upcoming earnings.

abrdn ETF - abrdn Physical Silver Shares ETF

SIVR is trending amid strong community discussion about a significant and growing disconnect between the 'paper' price of silver on exchanges and the higher premiums observed in the physical markets, particularly in Asia. Investors are actively debating the implications of this divergence, often attributing it to market manipulation and anticipating a major upward re-pricing of silver driven by robust industrial demand, supply deficits, and geopolitical uncertainties.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the S&P Biotech Select Industry Index (XBI) shows unusual resilience and continued bullish momentum, leading to significant frustration among investors anticipating a sector pullback. Despite widespread calls for a reversal based on technical divergences and broader economic concerns, XBI's strength, potentially fueled by M&A and market rotation, has left many "bag holding" this inverse ETF while keenly debating future entry opportunities.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is trending due to significant community interest in acquiring the newly launched token, which has seen rapid growth in market capitalization and holder count. However, conversation is actively shaped by user confusion and reported discrepancies concerning its availability and pricing on platforms like Coinbase, alongside a debate between optimistic growth predictions and concerns over its legitimacy.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as reports of a significantly increased valuation for its strategic investment in ClickHouse are generating excitement and seen as bolstering NBIS's underlying assets. This, coupled with new analyst coverage, fuels strong community discussions about the company's long-term potential in the surging AI infrastructure market. While many investors are confident in future hyperscaler deals, some express frustration over persistent intraday volatility and perceived price fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SB Financial Group, Inc. (NASDAQ:SBFG) Short Interest Up 29.4% in December

SB Financial Group, Inc. (NASDAQ:SBFG - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 120,101 shares, an...

SB Financial Group (SBFG) Upgraded to Strong Buy: What Does It Mean for the Stock?

SB Financial Group (SBFG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SB Financial Group, Inc. $SBFG Shares Sold by Strategic Value Bank Partners LLC

Strategic Value Bank Partners LLC decreased its position in shares of SB Financial Group, Inc. (NASDAQ:SBFG - Free Report) by 21.0% during the third quarter, according to its most recent 13F filing...

Best Value Stocks to Buy for December 30th

VALE, EVTC and SBFG made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 30, 2025.

SB Financial Group (NASDAQ:SBFG) Share Price Passes Above 50 Day Moving Average - What's Next?

SB Financial Group (NASDAQ:SBFG) Stock Passes Above 50-Day Moving Average - Time to Sell...

Are Investors Undervaluing SB Financial Group (SBFG) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SB Financial Group (SBFG) Is a Great Choice for 'Trend' Investors, Here's Why  

SB Financial Group (SBFG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

FJ Capital Management LLC Sells 105,780 Shares of SB Financial Group, Inc. $SBFG

FJ Capital Management LLC cut its holdings in shares of SB Financial Group, Inc. (NASDAQ:SBFG - Free Report) by 28.5% during the 2nd quarter, according to its most recent disclosure with the...

SB Financial Group (NASDAQ:SBFG) Share Price Crosses Above 50-Day Moving Average - Time to Sell?

SB Financial Group (NASDAQ:SBFG) Share Price Crosses Above 50 Day Moving Average - What's Next...

Shore Bancshares Inc (SHBI) Hit a 52 Week High, Can the Run Continue?

Shore Bancshares (SHBI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

SB Financial Group, Inc. is a financial holding company, which engages in the provision of commercial banking and wealth management solutions. The company offers checking, savings, e-services, mortgage loans, mortgage applications, mortgage tool, credit cards, and loans and lines services. It also provides investment and asset management, retirement services, insurance, business succession planning, and brokerage services. The company was founded in 1983 and is headquartered in Defiance, OH.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.64	--	--	N/A
Q3 '25	$0.62	$0.68	9.68%	BEAT
Q2 '25	$0.54	$0.58	7.41%	BEAT
Q1 '25	$0.40	$0.42	5.00%	BEAT
Q4 '24	$0.41	$0.52	26.83%	BEAT

SBFG
SB Financial Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SBFG News

SBFGSB Financial Group Inc